Retrospective Study
Copyright ©The Author(s) 2024.
World J Diabetes. Dec 15, 2024; 15(12): 2285-2292
Published online Dec 15, 2024. doi: 10.4239/wjd.v15.i12.2285
Table 1 General characteristics between type 2 diabetes mellitus patients and controls

T2DM (n = 196)
Control (n = 60)
t
P value
Age (years)72.06 ± 4.8771.82 ± 4.280.3490.723
Course of diabetes mellitus (years)15.24 ± 2.08-
BMI (kg/m2)24.58 ± 2.4725.04 ± 2.451.2610.208
FBG (mmol/L)9.69 ± 2.305.34 ± 0.6014.49< 0.0001
HbA1c (%)9.14 ± 1.785.64 ± 0.8514.74< 0.0001
Total cholesterol (mmol/L)4.27 ± 1.394.64 ± 1.031.8970.059
Triglyceride (mmol/L)1.73 ± 0.811.84 ± 0.610.9670.335
High-density lipoprotein (mmol/L)1.13 ± 0.301.26 ± 0.262.9070.004
Low-density lipoprotein (mmol/L)2.51 ± 0.922.86 ± 0.672.6620.008
25(OH)D3 (ng/mL)21.87 ± 7.8531.42 ± 9.337.875< 0.0001
Femoral neck BMD0.76 ± 0.130.79 ± 0.121.4690.143
Total hip BMD0.87 ± 0.140.95 ± 0.113.8550.0001
Lumbar spine L1-4 BMD0.91 ± 0.200.97 ± 0.161.6120.108
Table 2 Comparison between type 2 diabetes mellitus patients with and without sarcopenia

Sarcopenia group (n = 51)
Non-sarcopenia group (n = 145)
t
P value
Age (years)71.41 ± 4.8772.29 ± 4.871.1080.269
Course of diabetes mellitus (years)16.84 ± 3.3114.68 ± 0.917.130< 0.0001
BMI (kg/m2)23.11 ± 2.125.10 ± 2.365.263< 0.0001
FBG (mmol/L)9.59 ± 2.319.72 ± 2.300.3690.712
HbA1c (%)9.14 ± 1.719.15 ± 1.810.0100.992
Total cholesterol (mmol/L)3.99 ± 1.244.37 ± 1.431.6680.097
Triglyceride (mmol/L)1.54 ± 0.731.80 ± 0.831.2390.217
High-density lipoprotein (mmol/L)1.09 ± 0.251.15 ± 0.321.1530.250
Low-density lipoprotein (mmol/L)2.42 ± 0.862.55 ± 0.940.8840.378
25(OH)D3 (ng/mL)19.17 ± 6.3922.82 ± 8.112.9170.004
Table 3 Comparison of body composition and functional indexes

Sarcopenia group (n = 51)
Non-sarcopenia group (n = 145)
t
P value
BMI (kg/m2)23.11 ± 2.125.10 ± 2.365.263< 0.0001
ASM (kg)19.10 ± 1.6023.42 ± 2.7310.66< 0.0001
ASMI (kg/m2)6.50 ± 0.488.28 ± 0.5221.44< 0.0001
Left-hand grip strength (kg)25.45 ± 4.0337.68 ± 4.8216.23< 0.0001
Right-hand grip strength (kg)26.45 ± 2.7239.02 ± 4.7617.86< 0.0001
Gait speed (m/s)0.60 ± 0.161.27 ± 0.1625.91< 0.0001
Upper limb muscle mass (kg)4.82 ± 0.455.93 ± 0.7510.02< 0.0001
Lower limb muscle mass (kg)15.13 ± 1.2817.74 ± 1.5710.68< 0.0001
Upper limb fat mass (kg)2.58 ± 0.493.00 ± 0.475.398< 0.0001
Lower limb fat mass (kg)4.57 ± 1.255.59 ± 1.494.398< 0.0001
Table 4 Correlation between bone mineral density and function in different body parts of diabetic patients
Femoral neck
Total hip
Lumbar spine L1-4
r
P value
r
P value
r
P value
ASM (kg)0.348< 0.00010.309< 0.00010.422< 0.0001
ASMI (kg/m2)0.557< 0.00010.407< 0.00010.582< 0.0001
Left-hand grip strength (kg)0.487< 0.00010.398< 0.00010.557< 0.0001
Right-hand grip strength (kg)0.453< 0.00010.455< 0.00010.598< 0.0001
Gait speed (m/s)0.538< 0.00010.455< 0.00010.612< 0.0001
Upper limb muscle mass (kg)0.438< 0.00010.2460.00050.368< 0.0001
Lower limb muscle mass (kg)0.447< 0.00010.356< 0.00010.449< 0.0001
Upper limb fat mass (kg)0.2640.00020.1550.0300.2330.001
Lower limb fat mass (kg)0.1960.0060.1140.1110.296< 0.0001
Table 5 Logistic regression analysis of sarcopenia in diabetic patients
Factors
β
SE
Wald
P value
HR
95%CI
DM course (> 14.8)1.7190.5948.3860.0045.5801.743-17.866
BMI (≤ 24.8)1.2750.6024.4800.0343.5771.099-11.644
25(OH)D3 (≤ 21.58)0.3620.5800.3890.5331.4360.461-4.475
Femoral neck BMD (≤ 0.76)2.6100.70313.7760.00013.5943.427-53.929
Total hip BMD (≤ 0.86)2.4570.66213.7850.00011.6683.190-42.682
Lumbar spine L1-4 BMD (≤ 0.92)4.0490.87621.3830.00057.33110.306-318.929
Constant-9.4801.47040.6130.0000.000-